Larvol Delta - Safety-and-Tolerability-of-KH631-Gene-Therapy-in-Participants-With-Neovascular-Agerelated-Macular-Degeneration

KH631 - Chengdu Kanghong Pharma

http://clinicaltrials.gov/ct2/show/NCT05657301

Jan 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next